Supplementary Table 1. Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort

Supplementary Table 1. Patient demographics and baseline characteristics in the French cohort of the CORRELATE study, stratified by regorafenib starting dose.